Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Recs

0
Player Avatar cashsage (30.40) Submitted: 11/13/2009 12:05:26 PM : Underperform Start Price: $1.90 IDIX Score: -389.02

IDIX has a too high valuation compared to its sales potential. It is also loss making.

Featured Broker Partners


Advertisement